Janux Therapeutics, Inc.
JANX
$29.69
$1.003.49%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 197.99% | 88.16% | 113.09% | 105.68% | 5.20% |
Total Receivables | 149.01% | 162.00% | 703.73% | 203.79% | 208.71% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.97% | 1.40% | -20.45% | -18.74% | -35.38% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 195.97% | 87.59% | 114.01% | 104.94% | 5.05% |
|
|||||
Total Current Assets | 195.97% | 87.59% | 114.01% | 104.94% | 5.05% |
Net Property, Plant & Equipment | -13.26% | -12.15% | -10.13% | -7.39% | -5.19% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 11.28% | 16.26% | 6.37% | 37.62% | 50.73% |
Total Assets | 179.05% | 79.66% | 102.46% | 95.20% | 4.50% |
|
|||||
Total Accounts Payable | 66.09% | -1.72% | -34.40% | 9.90% | 12.27% |
Total Accrued Expenses | 58.17% | 90.63% | -7.03% | -24.91% | -9.68% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 15.29% | 15.53% | 15.77% | 16.00% | 98.82% |
Total Finance Division Other Current Liabilities | -- | -- | -98.25% | -80.44% | -68.46% |
Total Other Current Liabilities | -- | -- | -98.25% | -80.44% | -68.46% |
Total Current Liabilities | 33.96% | 18.67% | -35.52% | -34.16% | -21.05% |
|
|||||
Total Current Liabilities | 33.96% | 18.67% | -35.52% | -34.16% | -21.05% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -7.60% | -7.21% | -6.84% | -6.50% | -6.18% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 7.42% | 2.67% | -19.74% | -20.32% | -16.67% |
|
|||||
Common Stock & APIC | 145.56% | 70.73% | 90.32% | 90.90% | 18.42% |
Retained Earnings | -40.88% | -38.56% | -30.28% | -43.46% | -52.77% |
Treasury Stock & Other | 225.26% | 766.47% | -52.45% | 29.09% | 143.32% |
Total Common Equity | 197.02% | 88.02% | 119.61% | 110.68% | 7.36% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 197.02% | 88.02% | 119.61% | 110.68% | 7.36% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 197.02% | 88.02% | 119.61% | 110.68% | 7.36% |
|